|
61
|
220
|
5lf1H |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
59
|
195
|
5l65J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
240
|
5l68C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
70
|
243
|
5l65F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
211
|
5l5wK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
62
|
234
|
5lezE |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
64
|
239
|
5lf0F |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
64
|
241
|
5l65G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
70
|
233
|
5l5rM |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
57
|
204
|
5l62I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
61
|
234
|
5leyE |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
59
|
226
|
5l5wH |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
66
|
216
|
5lf3M |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
67
|
239
|
5lf1F |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
68
|
240
|
5l6cC |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
54
|
196
|
5le5J |
Native human 20s proteasome at 1.8 angstrom |
|
70
|
244
|
5l67B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
237
|
5lf7C |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
59
|
226
|
5l5qH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
57
|
204
|
5l5vI |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
226
|
5l6cH |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
213
|
5lf7L |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
61
|
222
|
5m2bL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
60
|
195
|
5l5sJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
69
|
244
|
5l60B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
53
|
204
|
5lf0I |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
58
|
195
|
5l67J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
60
|
222
|
5l6bL |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
65
|
211
|
5l6aK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
62
|
220
|
5lezH |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
250
|
5l63A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
69
|
242
|
5l66D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
62
|
211
|
5lttK |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
58
|
195
|
5l63J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
237
|
5lexC |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
63
|
231
|
5l5vE |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
57
|
195
|
5l62J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
65
|
230
|
5lf7A |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
63
|
241
|
5lttG |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
70
|
243
|
5l6bF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
233
|
5l64M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
67
|
240
|
5l5vC |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
70
|
240
|
5l62C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
200
|
5leyK |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
54
|
196
|
5lf3J |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
58
|
204
|
5l5sI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
62
|
220
|
5le5H |
Native human 20s proteasome at 1.8 angstrom |
|
64
|
211
|
5l64K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
68
|
213
|
5lf4L |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
57
|
204
|
5l5rI |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
